Effectiveness of Original vs. AI-Generated Plain Language Summaries of Systematic Reviews
Patients' Perceptions and Comprehension of Original Versus AI-Generated Plain Language Summaries of Cochrane Oncology Systematic Reviews
2 other identifiers
interventional
130
1 country
1
Brief Summary
The study explores how patients with non-metastatic breast cancer perceive and comprehend original Plain Language Summary and AI-generated Plain Language Summary (PLS) of two systematic reviews from the Cochrane Library. The systematic reviews address exercise during adjuvant therapy and psychological interventions for non-metastatic breast cancer. The study, which is randomized and double-blind, aims to assess whether AI-generated PLS and original PLS differ in their influence on patients' intention to undertake and apply the recommendation presented in the summary, as well as their overall understanding of the study results.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 14, 2025
CompletedFirst Submitted
Initial submission to the registry
August 18, 2025
CompletedFirst Posted
Study publicly available on registry
August 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2026
CompletedAugust 24, 2025
August 1, 2025
6 months
August 18, 2025
August 18, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patients' level of intention for changing their behavior
Patients' level of intention for changing their behavior and start applying the interventions described in the summary, measured on a visual analogue scale (VAS) ranging from 0 to 100 (do not agree at all to 100 fully agree).
Immediately after reading individual PLS
Secondary Outcomes (4)
Patients' comprehension of the information presented in the summary
Immediately after reading individual PLS
Patients' level of trust in the information presented
Immediately after reading individual PLS
Patients' level of perceived clarity in the information
Immediately after reading individual PLS
Patient's level of confidence in their decision to change behavior
Immediately after reading individual PLS
Study Arms (2)
Patients Receiving AI-generated Plain Language Summaries
EXPERIMENTALExperimental Group: participants in this group receive two AI-generated Plain Language Summaries based on the scientific abstract of two Cochrane systematic reviews: Exercise during Adjuvant Therapy (1) and Psychological Interventions for Non-metastatic Breast Cancer (2).
Patients Receiving Original Plain Language Summaries
ACTIVE COMPARATORActive Comparative Group: participants in this group receive two original Plain Language Summaries based on the scientific abstract of two Cochrane systematic reviews: Exercise during Adjuvant Therapy (1) and Psychological Interventions for Non-metastatic Breast Cancer (2).
Interventions
Reading AI-generated Plain Language Summaries of two Cochrane systematic reviews covering the same two evidence-based topics: exercise during adjuvant therapy and psychological interventions for non-metastatic breast cancer.
Reading original Plain Language Summaries of two Cochrane systematic reviews covering the same two evidence-based topics: exercise during adjuvant therapy and psychological interventions for non-metastatic breast cancer.
Eligibility Criteria
You may qualify if:
- female patients with histologically confirmed non-metastatic breast cancer currently undergoing chemotherapy or radiotherapy:
- neoadjuvant chemotherapy (with or without immunotherapy or antiHER2 therapy),
- adjuvant chemotherapy (with or without immunotherapy or antiHER2 therapy),
- adjuvant radiotherapy (including local and locoregional radiation treatment with possible radiotherapy boost where indicated).
- patients need to be able to read and understand Croatian.
You may not qualify if:
- female patients with metastatic breast cancer.
- female patients receiving only hormonal treatment.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Oncology and Radiotherapy, University Hospital Split
Split, 21000, Croatia
Related Publications (18)
Hasannejadasl H, Roumen C, Smit Y, Dekker A, Fijten R. Health Literacy and eHealth: Challenges and Strategies. JCO Clin Cancer Inform. 2022 Sep;6:e2200005. doi: 10.1200/CCI.22.00005.
PMID: 36194843BACKGROUNDSeiler A, Jenewein J. Resilience in Cancer Patients. Front Psychiatry. 2019 Apr 5;10:208. doi: 10.3389/fpsyt.2019.00208. eCollection 2019.
PMID: 31024362BACKGROUNDGoerling U, Faller H, Hornemann B, Honig K, Bergelt C, Maatouk I, Stein B, Teufel M, Erim Y, Geiser F, Niecke A, Senf B, Wickert M, Buttner-Teleaga A, Weis J. Information needs in cancer patients across the disease trajectory. A prospective study. Patient Educ Couns. 2020 Jan;103(1):120-126. doi: 10.1016/j.pec.2019.08.011. Epub 2019 Aug 12.
PMID: 31474389BACKGROUNDDiefenbach M, Turner G, Carpenter KM, Sheldon LK, Mustian KM, Gerend MA, Rini C, von Wagner C, Gritz ER, McQueen A, Prayor-Patterson HM, Miller SM. Cancer and patient-physician communication. J Health Commun. 2009;14 Suppl 1(Suppl 1):57-65. doi: 10.1080/10810730902814079.
PMID: 19449269BACKGROUNDRosa WE, Levoy K, Doyon K, McDarby M, Ferrell BR, Parker PA, Sanders JJ, Epstein AS, Sullivan DR, Rosenberg AR. Integrating evidence-based communication principles into routine cancer care. Support Care Cancer. 2023 Sep 8;31(10):566. doi: 10.1007/s00520-023-08020-x.
PMID: 37682354BACKGROUNDBuljan I, Tokalic R, Roguljic M, Zakarija-Grkovic I, Vrdoljak D, Milic P, Puljak L, Marusic A. Framing the numerical findings of Cochrane plain language summaries: two randomized controlled trials. BMC Med Res Methodol. 2020 May 6;20(1):101. doi: 10.1186/s12874-020-00990-4.
PMID: 32375659BACKGROUNDGainey K, Smith J, McCaffery K, Clifford S, Muscat D. Are plain language summaries published in health journals written according to instructions and health literacy principles? A systematic environmental scan. BMJ Open. 2024 Nov 27;14(11):e086464. doi: 10.1136/bmjopen-2024-086464.
PMID: 39608994BACKGROUNDBanic A, Fidahic M, Suto J, Roje R, Vuka I, Puljak L, Buljan I. Conclusiveness, linguistic characteristics and readability of Cochrane plain language summaries of intervention reviews: a cross-sectional study. BMC Med Res Methodol. 2022 Sep 10;22(1):240. doi: 10.1186/s12874-022-01721-7.
PMID: 36088293BACKGROUNDZaretsky J, Kim JM, Baskharoun S, Zhao Y, Austrian J, Aphinyanaphongs Y, Gupta R, Blecker SB, Feldman J. Generative Artificial Intelligence to Transform Inpatient Discharge Summaries to Patient-Friendly Language and Format. JAMA Netw Open. 2024 Mar 4;7(3):e240357. doi: 10.1001/jamanetworkopen.2024.0357.
PMID: 38466307BACKGROUNDArnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, Vignat J, Gralow JR, Cardoso F, Siesling S, Soerjomataram I. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast. 2022 Dec;66:15-23. doi: 10.1016/j.breast.2022.08.010. Epub 2022 Sep 2.
PMID: 36084384BACKGROUNDSoldato D, Arecco L, Agostinetto E, Franzoi MA, Mariamidze E, Begijanashvili S, Brunetti N, Spinaci S, Solinas C, Vaz-Luis I, Di Meglio A, Lambertini M. The Future of Breast Cancer Research in the Survivorship Field. Oncol Ther. 2023 Jun;11(2):199-229. doi: 10.1007/s40487-023-00225-8. Epub 2023 Apr 1.
PMID: 37005952BACKGROUNDNardin S, Mora E, Varughese FM, D'Avanzo F, Vachanaram AR, Rossi V, Saggia C, Rubinelli S, Gennari A. Breast Cancer Survivorship, Quality of Life, and Late Toxicities. Front Oncol. 2020 Jun 16;10:864. doi: 10.3389/fonc.2020.00864. eCollection 2020.
PMID: 32612947BACKGROUNDShaikh H, Bradhurst P, Ma LX, Tan SYC, Egger SJ, Vardy JL. Body weight management in overweight and obese breast cancer survivors. Cochrane Database Syst Rev. 2020 Dec 11;12(12):CD012110. doi: 10.1002/14651858.CD012110.pub2.
PMID: 33305350BACKGROUNDSuto Pavicic J, Marusic A, Buljan I. Using ChatGPT to Improve the Presentation of Plain Language Summaries of Cochrane Systematic Reviews About Oncology Interventions: Cross-Sectional Study. JMIR Cancer. 2025 Mar 19;11:e63347. doi: 10.2196/63347.
PMID: 40106236BACKGROUNDSuto J, Marusic A, Buljan I. Linguistic analysis of plain language summaries and corresponding scientific summaries of Cochrane systematic reviews about oncology interventions. Cancer Med. 2023 May;12(9):10950-10960. doi: 10.1002/cam4.5825. Epub 2023 Mar 23.
PMID: 36951519BACKGROUNDStephan D, Bertsch AS, Schumacher S, Puladi B, Burwinkel M, Al-Nawas B, Kammerer PW, Thiem DG. Improving Patient Communication by Simplifying AI-Generated Dental Radiology Reports With ChatGPT: Comparative Study. J Med Internet Res. 2025 Jun 9;27:e73337. doi: 10.2196/73337.
PMID: 40489773BACKGROUNDFurmaniak AC, Menig M, Markes MH. Exercise for women receiving adjuvant therapy for breast cancer. Cochrane Database Syst Rev. 2016 Sep 21;9(9):CD005001. doi: 10.1002/14651858.CD005001.pub3.
PMID: 27650122BACKGROUNDJassim GA, Whitford DL, Hickey A, Carter B. Psychological interventions for women with non-metastatic breast cancer. Cochrane Database Syst Rev. 2015 May 28;(5):CD008729. doi: 10.1002/14651858.CD008729.pub2.
PMID: 26017383BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 18, 2025
First Posted
August 24, 2025
Study Start
August 14, 2025
Primary Completion
February 1, 2026
Study Completion
February 1, 2026
Last Updated
August 24, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- Anonymous dataset will be available with the publication of the study.
- Access Criteria
- Anyone
Anonymous dataset from the study.